Hemopressin || Cayman Chemical

Hemopressin

Cayman Chemical Item Number 10011038

Description

Rat hemopressin is a bioactive peptide fragment derived from the hemoglobin α1 chain. Hemopressin exhibits potent vasoactive biological activity, reducing rat blood pressure over a dosage range of 0.1-10 μg/kg.¹ This peptide is also a potent central cannabinoid (CB₁) receptor antagonist conferring analgesia and pain relief or antinociception in vivo.² Further studies will clarify the cellular and physiological effects of hemopressin, as well the possible products of endopeptidase activity on hemopressin.^1,2 This peptide is sparingly soluble in water and the following resuspension technique is recommended. Bring the peptide to room temperature and empty the contents of the vial into a 25 ml graduated cylinder. Use 1 mL serial aliquots of sterile filtered water to dissolve any remaining peptide in the glass vial to quantitatively transfer the total amount to the cylinder. Finally, add sterile filtered water to 20 ml final volume and mix gently to dissolve fully. One milligram of hemopressin dissolved in 20 ml water provides a 45.9 µM solution. One milligram per milliliter concentrations of hemopressin may also be prepared with the use of 10% methanol in water containing 0.1% trifluoroacetic acid.

1 Goto, H., Kiyono, T., Tomono, Y., et al. Complex formation of Plk1 and INCENP required for metaphase-anaphase transition. Nat Cell Biol 8 180-187 (2005).

2 Heimann, A.S., Gomes, I., Dale, C.S., et al. Hemopressin is an inverse agonist of CB₁ cannabinoid receptors. Proc Natl Acad Sci USA 104(51) 20588-20593 (2007).

Formulation

1 mg peptide

Stability

1 year

Storage

-20°C

Shipping

Room temperature in continental US; may vary elsewhere

Background Reading

Rioli, V., Gozzo, F.C., Heimann, A.S., et al. Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotension-converting enzyme. J Biol Chem 278(10) 8547-8555 (2003).

Heimann, A.S., Gomes, I., Dale, C.S., et al. Hemopressin is an inverse agonist of CB₁ cannabinoid receptors. Proc Natl Acad Sci USA 104(51) 20588-20593 (2007).